Imprimis to Feature its Cyclosporine/Chondroitin Sulfate and Non-Opioid MKO Melt Formulations at the Upcoming ASCRS Meeting

Source: Imprimis Pharmaceuticals

Imprimis Pharmaceuticals and its ophthalmology-focused ImprimisRx division announced its participation and related physician presentations at the 2018 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting to be held at the Walter E. Washington Convention Center in Washington, DC, April 13-17.

At the conference, attendees will have the opportunity to meet with Imprimis representatives in booth #2218 to learn about Imprimis’ proprietary formulations and its recently launched “Custom Compound Program.” This new program provides high-quality compounded medications that are often difficult to find and typically needed quickly.

Imprimis formulations will be featured in the following sessions during ASCRS:

  • Clinical Outcomes after Use of New Combinations of Topical Antiocular Hypertensive Medications to Maintain or Lower IOP in Patients with Glaucoma – Inder Paul Singh, MD
    • E-poster
  • Dropless Cataract Surgery: Alternative Advanced Drug-Delivery Method for Cataract Surgery Patients – Abdullah Nasser, MD, Barry Emara, MD
    • Session: SPS – 308 Medications
    • Monday, April 16 – 2:28 PM-2:33 PM
    • Level 1, 143B

Additional formulations and ordering information will be available at Booth #2218 in the exhibit hall at the Walter E. Washington Convention Center.

Related Content